OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: University of Pennsylvania

5 Projects | 4 Researchers | $912,005 Invested

2025

University of Pennsylvania

James Shorter, PhD

Defining oligonucleotide therapeutics that reverse FUS proteinopathy

  • Funding Amount: $350,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Proteostasis
  • Status: Active

2010

University of Pennsylvania

Carlo Ballatore, PhD

Optimization of Aminothienopyridazine Inhibitors of Tau Aggregation

  • Funding Amount: $110,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2007

University of Pennsylvania

Christos Davatzikos, PhD

Predicting conversion from MCI to AD via 4-dimensional pattern analysis and classification of ADNI imaging data

  • Funding Amount: $98,484
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed

2003

University of Pennsylvania

Mei-Ping Kung, PhD

Evaluation of Anti-Plaque Treatment for Alzheimer's Disease

  • Funding Amount: $90,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2000

University of Pennsylvania

Mei-Ping Kung, PhD

Inhibitors of Beta Amyloid Aggregates: Characterization of Radio-odinated Ligands for Beta-Amyloids

  • Funding Amount: $263,521
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed